Improving the Recognition and Management of

Neurogenic Orthostatic Hypotension


Phillip A Low

Phillip A. Low, MD
Mayo Clinic College
    of Medicine
Rochester, Minnesota

Gwyn M. Vernon

Gwyn M. Vernon,

Parkinson’s Disease and
    Movement Disorders Center
University of Pennsylvania
Philadelphia, Pennsylvania


Neurogenic orthostatic hypotension (NOH) is uncommon compared with non-neurogenic orthostatic hypotension. Nevertheless, clinicians should have a high index of suspicion for this disorder in patients with underlying neurologic diseases. NOH can cause debilitating symptoms and contribute to increased risk of falls, impairing activities of daily living. This 1-credit CE/CME activity for nurse practitioners and physician assistants addresses diagnostic assessment, current pharmacotherapy options, lifestyle intervention, and patient education.

eNewsletter in Printable Format

Release Date: February 22, 2017
Expiration Date: February 22, 2018


Disclaimer: The materials presented here do not necessarily reflect the views of Continuing Education Alliance, Practicing Clinicians Exchange, or companies that provide educational support for programming on These activities may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. Readers should verify all information and data before treating patients or implementing any therapies described in these educational activities. © 2017 Continuing Education Alliance and Practicing Clinicians Exchange. All Rights Reserved. Terms and Conditions.